Analysis of very elderly (≥80years) non-hodgkin lymphoma: Impact of functional status and co-morbidities on outcome

Chadi Nabhan, Sonali M. Smith, Irene Helenowski, Erika Ramsdale, Benjamin Parsons, Reem Karmali, Josephine Feliciano, Britt Hanson, Scott Smith, June Mckoy, Annette Larsen, Andrew Hantel, Stephanie Gregory, Andrew M. Evens

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Abstract

Data on outcome, prognostic factors, and treatment for very elderly non-Hodgkin lymphomas (NHL) is sparse. We conducted a multicentre retrospective analysis of NHL patients ≥80years (at diagnosis) treated between 1999 and 2009. Detailed characteristics were obtained including geriatric syndromes, activities of daily living (ADLs), and co-morbidities using the Cumulative Illness Rating Scale-Geriatrics (CIRS-G). We identified 303 patients: 170 aggressive NHL (84% B cell/16% T cell) and 133 indolent NHL (82% B cell/18% T cell). Median age was 84years (80-95). A geriatric syndrome was present in 26% of patients, 18% had ≥1 grade 4 CIRS-G, and 14% had loss of ADLs. At 49-month median follow-up, 4-year progression-free (PFS) and overall survival (OS) for aggressive NHLs were 31% and 44% respectively (stage I/II: PFS 53% and OS 66%; stage III/IV: PFS 20% and OS 32%; P<0·0001 and 0·0002, respectively). Four-year PFS and OS for indolent NHL were 44% and 66% respectively, regardless of stage. Multivariate regression analysis identified two key factors that predicted inferior PFS and OS for both NHL groups: lack of CR and loss of ADLs. Prospective studies for very elderly NHL that incorporate geriatric tools, especially ADLs, are warranted.

Original languageEnglish (US)
Pages (from-to)196-204
Number of pages9
JournalBritish journal of haematology
Volume156
Issue number2
DOIs
StatePublished - Jan 2012
Externally publishedYes

Keywords

  • Co-morbidities
  • Elderly
  • Functional status
  • Geriatric syndromes
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Analysis of very elderly (≥80years) non-hodgkin lymphoma: Impact of functional status and co-morbidities on outcome'. Together they form a unique fingerprint.

Cite this